Endo Biologics Limited
11
James L. Garrity Jr.
05/31/2023
12/05/2024
Yes
v
| MEGANY, MEGA, JtAdm, CLMAGT |
Assigned to: Judge James L. Garrity Jr. Chapter 11 Voluntary Asset |
|
Debtor Operand Pharmaceuticals II Limited
1400 Atwater Drive Malvern, PA 19355 CHESTER-PA Tax ID / EIN: 00-0000000 aka Zoo Universal Pharmaceuticals II Limited |
represented by |
Lisa Laukitis
Skadden, Arps, Slate, Meagher & Flom LLP One Manhattan West New York, NY 10001-8602 212-735-3000 Fax : 212-735-2000 Email: lisa.laukitis@skadden.com Paul D. Leake
Skadden, Arps, Slate, Meagher & Flom LLP One Manhattan West New York, NY 10001 212-735-3000 Fax : 212-735-2000 Email: paul.leake@skadden.com Kyle J. Ortiz
Togut, Segal & Segal LLP One Penn Plaza Suite 3335 New York, NY 10119 212-594-5000 Fax : 212-967-4258 Email: kortiz@teamtogut.com |
U.S. Trustee United States Trustee
Office of the United States Trustee - NY Alexander Hamilton Custom House One Bowling Green, Room 534 New York, NY 10004-1408 (212) 510-0500 |
| |
Claims and Noticing Agent Kroll Restructuring Administration LLC Claims Agent
(Formerly Prime Clerk LLC) 55 East 52nd Street 17th Floor www.kroll.com New York, NY 10055 (212) 257-5450 |
| Date Filed | # | Docket Text |
|---|---|---|
| 07/17/2023 | Pending Deadlines Terminated: All Schedules and Statements. (Rodriguez, Willie) (Entered: 07/17/2023) | |
| 07/14/2023 | 9 | Statement of Financial Affairs - Non-Individual /Global Notes and Statement of Financial Affairs for Operand Pharmaceuticals II Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited. (Ortiz, Kyle) (Entered: 07/14/2023) |
| 07/14/2023 | 8 | Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Global Notes and Summary and Schedules of Assets and Liabilities for Operand Pharmaceuticals II Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited. (Ortiz, Kyle) (Entered: 07/14/2023) |
| 07/06/2023 | 7 | Order signed on 7/6/2023 Granting Motion To Extend Deadline to File Schedules or Provide Required Information: Deadline: 7/14/2023 (Related Doc # 3) (Rodriguez, Willie) (Entered: 07/06/2023) |
| 07/06/2023 | Deficiencies Set: Schedule A/B due 6/14/2023. Schedule D due 6/14/2023. Schedule E/F due 6/14/2023. Schedule G due 6/14/2023. Schedule H due 6/14/2023. Summary of Assets and Liabilities due 6/14/2023. Statement of Financial Affairs due 6/14/2023. Incomplete Filings due by 6/14/2023, (Porter, Minnie). (Entered: 07/06/2023) | |
| 06/30/2023 | 6 | Transcript regarding Hearing Held on 6/22/2023 at 11:09 AM RE: Motion to Extend Deadline to File Schedules or Provide Required Information. Remote electronic access to the transcript is restricted until 9/28/2023. The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: eScribers, LLC.]. (See the Courts Website for contact information for the Transcription Service Agency.) (RE: related document(s) 3). Notice of Intent to Request Redaction Deadline Due By 7/7/2023. Statement of Redaction Request Due By 7/21/2023. Redacted Transcript Submission Due By 7/31/2023. Transcript access will be restricted through 9/28/2023. (Ortiz, Carmen) (Entered: 06/30/2023) |
| 06/20/2023 | 5 | Certificate of No Objection Pursuant to LR 9075-2 /Certificate of No Objection to Motion of the Debtors for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs for the Additional Debtors and Any Future Debtors Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals II Limited. (Ortiz, Kyle) (Entered: 06/20/2023) |
| 06/16/2023 | 4 | Disclosure of Compensation of Attorney For Debtor (Rule 2016(b))- Form 2030 Filed by Lisa Laukitis on behalf of Operand Pharmaceuticals II Limited. (Laukitis, Lisa) (Entered: 06/16/2023) |
| 06/08/2023 | Claims and Noticing Agent, Kroll Restructuring Administration LLC, added to the case. (Rodriguez, Willie). (Entered: 06/08/2023) | |
| 06/08/2023 | Case Jointly Administrated with Case # 22-22549 per Order signed on 8/17/2023 in Case # 22-22549 Doc # 45. (Rodriguez, Willie) (Entered: 06/08/2023) |